Bcl-2 expression and allelic loss of the p53 gene in gastric carcinomas

Journal of Cancer Research and Clinical Oncology

Volumn 122, Issue 7, 1996, Pages 427-432

  Saegusa, Makoto ^a   Takano, Yasuo ^a   Kamata, Yoko ^a   Okayasu, Isao ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bcl 2; DCC; Gastric carcinoma; LOH; p53

Indexed keywords

PROTEIN BCL 2; PROTEIN P53;

ARTICLE; GENE EXPRESSION; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STOMACH CARCINOMA;

ALLELES; BASE SEQUENCE; CELL NUCLEUS; CYTOPLASM; GENE DELETION; GENE EXPRESSION; GENES, DCC; GENES, P53; HETEROZYGOTE; HUMANS; IMMUNOHISTOCHEMISTRY; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; STOMACH NEOPLASMS;

EID: 0029882053     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01212883     Document Type: Article

References (33)

1. Baas IO, Muldder J-WR, Offerhaus JA, Vogelstein B, Hamilton SR (1994) An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol 172:5-12
2. Bronner MP, Culin C, Reed JC, Furth EE (1995) The bcl-2 protooncogene and the gastrointestinal epithelial tumor progression model. Am J Pathol 146:20-26
3. Calle-Martin O de la, Fabregat V, Romero M, Soler J, Vives J, Yague J (1990) Acc II polymorphism of the p53 gene. Nucleic Acids Res 18:4963
4. Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61:759-767
5. Fearon ER, Cho KR, Nigro JM, Kern SE, Simons JW, Ruppert JM, Hamilton SR, Preisinger AC, Thomas G, Kinzler KW, Vogelstein B (1990) Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 247:49-56
6. Goelz SE, Hamilton SR, Vogelstein B (1985) Purification of DNA from formaldehyde fixed and paraffin embedded human tissue. Biochem Biophys Res Commun 130:118-126
7. Gorczyca W, Markiewski M, Kram A, Tuziak T, Domagala W (1995) Immunohistochemical analysis of bcl-2 and p53 expression in breast carcinomas: their correlation with Ki-67 growth fraction. Virchows Arch 426:229-233
8. Hahn M, Serth J, Fislage R, Wolfes H, Allhoff E, Jonas U, Pingoud A (1993) Polymerase chain reaction detection of a highly polymorphic VNTR segment in intron 1 of the human p53 gene. Clin Chem 39:549-550
9. Halder S, Negrini M, Monne M, Sabbioni S, Croce CM (1994) Down-regulation of bcl-2 by p53 in breast cancer cells. Cancer Res 54:2095-2097
10. Huang Y, Boynton RF, Blount PL, Silverstein RJ, Yin J, Tong Y, McDaniel TK, Newkirk C, Resau JH, Sridhara R, Reid BJ, Meltzer SJ (1992) Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers. Cancer Res 52:6525-6530
11. Joensuu H, Pylkkanen L, Toikkanen S (1994) Bcl-2 protein expression and long-term survival in breast cancer. Am J Pathol 145:1191-1198
12. Jones MH, Nakamura Y (1992) Detection of loss of heterozygosity at the human TP53 locus using a dinucleotide repeat polymorphism. Genes Chromosomes Cancer 5:89-90
13. Kim CJ, Kim WH, Kim CW, Lee JB, Lee CK, Kim YI (1995) Detection of 17p loss in gastric carcinoma using polymerase chain reaction. Lab Invest 72:232-236
14. Korsmeyer SJ (1992) Bcl-2 initiates a new category of oncogenes: regulation of cell death. Blood 80:879-886
15. Lauwers GY, Scott GV, Karpeh MS (1995) Immunohistochemical evaluation of bcl-2 protein expression in gastric adenocarcinomas. Cancer 75:2209-2213
16. Maesawa C, Tamura G, Suzuki Y, Ogasawara S, Sakata K, Kashiwaba M, Satodate R (1995) The sequential accumulation of genetic alterations characteristic of the colorectal adenoma-carcinoma sequence does not occur between gastric adenoma and adenocarcinoma. J Pathol 176:249-258
17. Matozaki M, Sakamoto C, Matsuda K, Suzuki T, Konda Y, Nakano O, Wada K, Uchida T, Nishisaki H, Nagao M, Kasuga M (1992) Missense mutations and a deletion of the p53 gene in human gastric cancer. Biochem Biophys Res Commun 182:215-223
18. McDonnell TJ, Troncoso P, Brisbay SM, Logothetis C, Chung LWK, Hsieh J-T, Tu S-M, Campbell ML (1992) Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res 52:6940-6944
19. Miyashita T, Harigai M, Hanada M, Reed JC (1994) Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res 54:3131-3135
20. Pezzella F, Turley H, Kuzu I, Tungekar MF, Dunnill MS, Pierce CB, Harris A, Gatter KC, Mason DY (1993) Bcl-2 protein in non-small-cell lung carcinoma. N Engl J Med 329:690-694
21. Pilotti S, Collini P, Rilke F, Cattoretti G, Bo RD, Pierotti MA (1994) Bcl-2 protein expression in carcinomas originating from the follicular epithelium of the thyroid gland. J Pathol 172:337-342
22. Renault B, Broek M van den, Fodde R, Wijnen J, Pellegata NS, Amadori D, Khan PM, Ranzani GN (1993) Base transitions are the most frequent genetic changes at p53 in gastric cancer. Cancer Res 53:2614-2617
23. Saegusa M, Takano Y, Hashimura M, Shoji Y, Okayasu I (1995a) A possible role for Bcl-2 expression in progression of tumor of the uterine cervix. Cancer 76:2297-2303
24. Saegusa M, Takano Y, Okayasu I (1995b) Bcl-2 expression and its association with cell kinetics in human gastric carcinomas and intestinal metaplasia. J Cancer Res Clin Oncol 121:357-363
25. Saegusa M, Takano Y, Wakabayashi T, Okayasu I (1995c) Apoptosis in gastric carcinomas and its association with cell proliferation and differentiation. Jpn J Cancer Res 86:743-748
26. Seruca R, David L, Holm R, Nesland JM, Fangan BM, Castedo S, Sobrinho-Simoes M, Borresen A-L (1992) p53 mutations in gastric carcinomas. Br J Cancer 65:708-710
27. Sinicrope FA, Ruan SB, Cleary KR, Stephens C, Lee JJ, Levin B (1995) bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res 55:237-241
28. Stemmermann G, Heffelfinger SC, Noffsinger A, Hui YZ, Miller MA, Fenoglio-Preiser CM (1994) The molecular biology of esophageal and gastric cancer and their precursors: oncogenes, tumor suppressor genes, and growth factors. Hum Pathol 25:968-981
29. Sugano H, Nakamura K, Kato Y (1982) Pathological studies of human gastric cancer. Acta Pathol Jpn 32:329-347
30. Tahara E (1993) Molecular mechanism of stomach carcinogenesis. J Cancer Res Clin Oncol 119:265-272
31. Tsujimoto Y, Finger LR, Yunis J, Nowell PC, Croce CM (1984) Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science 226:1097-1099
32. Uchino S, Tsuda H, Noguchi M, Yokota J, Terada M, Saito T, Kobayashi M, Sugimura T, Hirohashi S (1992) Frequent loss of heterozygosity at the DCC locus in gastric cancer. Cancer Res 52:3099-3102
33. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AMM, Bos JL (1988) Genetic alterations during colorectal-tumor development. N Engl J Med 319:525-532